1. Home
  2. ZYME vs PTEN Comparison

ZYME vs PTEN Comparison

Compare ZYME & PTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$23.23

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Patterson-UTI Energy Inc.

PTEN

Patterson-UTI Energy Inc.

HOLD

Current Price

$8.50

Market Cap

2.2B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
PTEN
Founded
2003
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
ZYME
PTEN
Price
$23.23
$8.50
Analyst Decision
Strong Buy
Hold
Analyst Count
9
10
Target Price
$32.75
$7.90
AVG Volume (30 Days)
484.1K
9.8M
Earning Date
03-30-2026
05-04-2026
Dividend Yield
N/A
4.76%
EPS Growth
5.81
90.16
EPS
N/A
N/A
Revenue
$76,304,000.00
$4,826,624,000.00
Revenue This Year
$63.10
N/A
Revenue Next Year
$93.26
$3.73
P/E Ratio
N/A
N/A
Revenue Growth
0.38
N/A
52 Week Low
$9.03
$5.10
52 Week High
$28.49
$8.91

Technical Indicators

Market Signals
Indicator
ZYME
PTEN
Relative Strength Index (RSI) 49.13 63.91
Support Level $22.22 $5.32
Resistance Level $23.66 $8.91
Average True Range (ATR) 0.84 0.35
MACD 0.15 -0.04
Stochastic Oscillator 45.85 65.68

Price Performance

Historical Comparison
ZYME
PTEN

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About PTEN Patterson-UTI Energy Inc.

Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.

Share on Social Networks: